IGF1R and breast carcinoma: Zhang et al have shown that downregulation of the IR inhibited metastasis of breast cancer cells in an athymic mouse model [29], and recent investigations have begun to assess the benefit of dual inhibition of the IGF1R and IR in models of osteosarcoma [30] and in pancreatic neuroendocrine carcinogenesis [31].